Merck Sharp & Dohme (I.A.) Corp.
Taipei, Taiwan
Corporate office
110, Taipei City, Xinyi District, Section 5, Xinyi Rd, 106號12樓
About Merck Sharp & Dohme (I.A.) Corp.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
3
Organon and Co
1
Clinical Trials at Merck Sharp & Dohme (I.A.) Corp.
During the past decade, Merck Sharp & Dohme (I.A.) Corp. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)
2005-05-01
2006-04-04
Completed
30
Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)
2011-01-01
2012-12-01
Completed
834
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
2015-12-18
2026-10-02
Recruiting
1,609
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
2016-11-17
2025-05-30
Recruiting
1,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Merck Sharp & Dohme (I.A.) Corp.
According to Clinical.Site data, the most researched conditions in "Merck Sharp & Dohme (I.A.) Corp." are
"Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "Merck Sharp & Dohme (I.A.) Corp." in a lesser frequency.
Clinical Trials Intervention Types at Merck Sharp & Dohme (I.A.) Corp.
Most popular intervention types in "Merck Sharp & Dohme (I.A.) Corp." are "Biological" (2 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abiraterone acetate 1000 mg" (1 trials), "Belzutifan 120mg" (1 trials), "Carboplatin" (1 trials), "Dexamethasone 8 mg" (1 trials) and "Docetaxel 75 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Merck Sharp & Dohme (I.A.) Corp.
The vast majority of trials in "Merck Sharp & Dohme (I.A.) Corp." are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Merck Sharp & Dohme (I.A.) Corp.
Currently, there are NaN active trials in "Merck Sharp & Dohme (I.A.) Corp.".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Merck Sharp & Dohme (I.A.) Corp.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Merck Sharp & Dohme (I.A.) Corp., 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".